Jonathan P. Mow

2020

In 2020, Jonathan P. Mow earned a total compensation of $1.8M as Chief Executive Officer at PhaseBio Pharmaceuticals, a 47% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$273,300
Option Awards$951,200
Salary$529,317
Other$9,819
Total$1,763,636

Mow received $951.2K in option awards, accounting for 54% of the total pay in 2020.

Mow also received $273.3K in non-equity incentive plan, $529.3K in salary and $9.8K in other compensation.

Rankings

In 2020, Jonathan P. Mow's compensation ranked 6,098th out of 13,090 executives tracked by ExecPay. In other words, Mow earned more than 53.4% of executives.

ClassificationRankingPercentile
All
6,098
out of 13,090
53rd
Division
Manufacturing
2,517
out of 5,618
55th
Major group
Chemicals And Allied Products
1,010
out of 2,251
55th
Industry group
Drugs
875
out of 1,951
55th
Industry
Pharmaceutical Preparations
653
out of 1,456
55th
Source: SEC filing on April 22, 2022.

Mow's colleagues

We found two more compensation records of executives who worked with Jonathan P. Mow at PhaseBio Pharmaceuticals in 2020.

2020

John Lee

PhaseBio Pharmaceuticals

Chief Medical Officer

2020

John Sharp

PhaseBio Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like